Back to all studies
RecruitingNCT05511909

Evaluating Buspirone to Treat Opioid Withdrawal

This study is recruiting. It focuses on anxiety and currently lists participation information in the United States.

Anxiety, Opioid Use Disorder, ...DrugFrom 18 Years to 75 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT05511909. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This summary needs review. Please check the official study record and contact the research team for details.

What to expect

Your next step

The official record suggests in-person participation through a lab, with sites including Kahlert Institute for Addictino Medicin in Baltimore. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually meeting the main study requirements, while common reasons not to take part include pregnancy or breastfeeding and other treatments that could interfere with the study. This is an early-stage study, which usually means a smaller group and a focus on learning how the approach behaves.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 15, 2023
Recruitment status
Recruiting
Estimated enrollment
Not clearly listed
Sponsor
University of Maryland, Baltimore
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT05511909
Official title
Evaluating Buspirone to Treat Opioid Withdrawal
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT05511909. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in United States.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring behavioral or lifestyle intervention for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with anxiety; age range: From 18 Years to 75 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by University of Maryland, Baltimore, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me